Washington’s message is changing: science-first reforms, fast-track approvals, and a critical Medicare fix. This is where the opportunity lies.
How to find and navigate value investments in public equities
Analyzing fragile markets and strategizing positioning moving forward
A deep dive into NVIDIA's heavy allegations
Why I believe Chinese equities are one of the smartest bets right now
How a tech executive might be hurting his seemingly-impressive company by dumping shares
